IP Library › Assignment 058639/0138
Patent Assignment
Reel/Frame 058639/0138

Assignment of Assignor's Interest

Recorded: 2022-01-04 Pages: 85
Assignor
REATA PHARMACEUTICALS, INC.
Executed: 2021-08-17
Assignee
REATA PHARMACEUTICALS HOLDINGS, LLC
5320 LEGACY DRIVE, PLANO, TEXAS, 75024
Covered Properties (30)
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxolone Methyl or Analogs Thereof
Application: 14/466,495 →
Publication: US 2015/0080465
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Application: 15/675,862 →
Publication: US 2018/0161311
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
Application: 16/130,242 →
Publication: US 2019/0076443
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxolone Methyl or Analogs Thereof
Application: 16/157,225 →
Publication: US 2019/0091194
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Application: 17/173,340 →
Publication: US 2021/0161914
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Application: 17/304,778 →
Publication: US 2021/0355156
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Application: 17/305,537 →
Publication: US 2022/0024862
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Patent: 8,124,799 →
Application: 12/426,778 →
Publication: US 2010/0048892
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Patent: 8,129,429 →
Application: 12/352,473 →
Publication: US 2009/0326063
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Patent: 8,440,854 →
Application: 13/356,455 →
Publication: US 2012/0214814
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Patent: 8,455,544 →
Application: 13/359,381 →
Publication: US 2012/0220652
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Patent: 8,993,640 →
Application: 13/869,833 →
Publication: US 2013/0324599
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Patent: 9,102,681 →
Application: 13/861,208 →
Publication: US 2013/0317007
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Patent: 9,670,147 →
Application: 14/753,297 →
Publication: US 2015/0376121
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Patent: 9,701,709 →
Application: 14/625,829 →
Publication: US 2015/0259377
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Patent: 9,757,359 →
Application: 13/886,053 →
Publication: US 2013/0345276
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Application: 15/615,393 →
Publication: US 2018/0002277
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
Application: 13/085,338 →
Publication: US 2011/0281955
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Application: 16/115,028 →
Publication: US 2019/0119202
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Application: 16/315,821 →
Publication: US 2019/0350941
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Application: 15/622,568 →
Publication: US 2018/0009839
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Application: 16/786,429 →
Publication: US 2020/0239410
Systhetic Triterpenoids and Methods of Use in the Treatment of Disease
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
2.2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxololone Methyl or Analogs Thereof
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Methods of Treating Covid-19 Using Bardoxolone Methyl or Analogs Thereof
Methods of Administering Synthetic Triterpenoids
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2009
From: SPORN, MICHAEL B.; LIBY, KAREN T.; GRIBBLE, GORDON W.; HONDA, TADASHI
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 022411/0782 →
Assignment of Assignor's Interest Mar 18, 2009
From: KRAL, ROBERT M.; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 022411/0713 →
Assignment of Assignor's Interest Sep 11, 2009
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 023217/0672 →
Assignment of Assignor's Interest Jun 10, 2011
From: MEYER, COLIN J.; HUFF, WARREN
To: REATA PHARMACEUTICALS
Reel/Frame 026427/0698 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 026427 Frame 0698. Assignor(S) Hereby Confirms the the Entire Right, Title, and Interest for the United States and All Foreign Countries in and to Any and All Improvements. Aug 23, 2012
From: MEYER, COLIN J.; HUFF, J. WARREN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 028840/0735 →
Assignment of Assignor's Interest Aug 14, 2013
From: DECKER, ANDREA
To: SOLVIAS AG
Reel/Frame 031006/0234 →
Assignment of Assignor's Interest Aug 14, 2013
From: SOLVIAS AG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 031006/0303 →
Assignment of Assignor's Interest Aug 14, 2013
From: ANDERSON, ERIC; LIU, XIAOFENG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 031006/0104 →
Assignment of Assignor's Interest Oct 2, 2014
From: CHIN, MELANIE PEI-HENG; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 033869/0469 →
Assignment of Assignor's Interest Oct 8, 2015
From: SPORN, MICHAEL B.; LIBY, KAREN T.; GRIBBLE, GORDON W.; HONDA, TADASHI
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 036757/0835 →
Assignment of Assignor's Interest Oct 8, 2015
From: KRAL, ROBERT M.; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 036758/0046 →
Assignment of Assignor's Interest Oct 8, 2015
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 036758/0575 →
Assignment of Assignor's Interest Oct 13, 2015
From: SOLVIAS AG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 036783/0285 →
Assignment of Assignor's Interest Oct 13, 2015
From: DECKER, ANDREA
To: SOLVIAS AG
Reel/Frame 036783/0089 →
Assignment of Assignor's Interest Oct 13, 2015
From: ANDERSON, ERIC; LIU, XIAOFENG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 036782/0867 →
Assignment of Assignor's Interest Jun 6, 2017
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 042618/0601 →
Assignment of Assignor's Interest Aug 14, 2017
From: KRAL, ROBERT M.; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043278/0640 →
Assignment of Assignor's Interest Aug 14, 2017
From: SPORN, MICHAEL B.; LIBY, KAREN T.; GRIBBLE, GORDON W.; HONDA, TADASHI
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 043539/0424 →
Security Interest Jun 14, 2018
From: REATA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 046357/0605 →
Assignment of Assignor's Interest Sep 26, 2018
From: MEYER, COLIN J.; HUFF, J. WARREN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 046974/0731 →
Assignment of Assignor's Interest Oct 11, 2018
From: CHIN, MELANIE PEI-HENG; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 047131/0022 →
Security Interest Oct 9, 2019
From: REATA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050670/0902 →
Release of Security Interest Jun 24, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 053034/0018 →
Assignment of Assignor's Interest Feb 11, 2021
From: MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 055226/0614 →
Assignment of Assignor's Interest Jun 25, 2021
From: SOLVIAS AG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056669/0249 →